CD8A and neoplasm: The phenomenon of antigen spreading, which corresponds to the secondary CD8+ T cell response against antigen epitopes that are not present in the vaccine but likely result from local release after the first wave of tumor‐specific CD8+ T cells, provides additional evidence for the important role of these effector cells.120